Alpha 2.0
Login Register
» Authors » Maxensia Owor

Maxensia Owor

Explore the profile of Maxensia Owor including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 539
Followers 0
Related Specialties
Infectious Diseases
General Medicine
Pediatrics
Top 10 Co-Authors
Mary Glenn Fowler
Dhayendre Moodley
Lameck Chinula
Taha E Taha
Lynda Stranix-Chibanda
Patricia M Flynn
Avy Violari
Sufia Dadabhai
Renee Browning
Nahida Chakhtoura
Published In
J Acquir Immune Defic Syndr
AIDS
Clin Infect Dis
Lancet
mSphere
Affiliations
Soon will be listed here.
Recent Articles
1.
Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother-infant pairs (MTN-043): a phase 3B, open-label, randomised trial
Noguchi L, Owor M, Mgodi N, Gati Mirembe B, Dadabhai S, Horne E, et al.
Lancet HIV . 2025 Feb; 12(3):e180-e190. PMID: 39954697
Background: In 2021, WHO recommended dapivirine vaginal rings (DVRs) for HIV prevention, but noted evidence gaps for breastfeeding populations. This trial aimed to describe safety profiles associated with DVRs and...
2.
Bone mineral density changes in breastfeeding women living with HIV on antiretroviral therapy in Eastern and Southern Africa
Kiweewa F, Stranix-Chibanda L, Yende-Zuma N, Dadabhai S, Owor M, Hanley S, et al.
AIDS . 2025 Feb; PMID: 39918445
Objective: To describe postpartum bone mineral density (BMD) change among breastfeeding African women living with HIV (WLHIV) on life-long antiretroviral therapy (ART). Design: In IMPAACT P1084 s, postpartum BMD declines...
3.
Characterizing HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trial
Bishop M, Korutaro V, Boyce C, Beck I, Styrchak S, Knowles K, et al.
J Acquir Immune Defic Syndr . 2024 Aug; 96(4):385-392. PMID: 39175843
Introduction: VESTED (NCT03048422) compared the safety and efficacy of three antiretroviral treatment () regimens in pregnant and postpartum women: dolutegravir+emtricitabine/tenofovir alafenamide fumarate; dolutegravir+emtricitabine/tenofovir disoproxil fumarate (); efavirenz/emtricitabine/TDF. Vertical HIV transmission...
4.
Effects of Combination Antiretroviral Therapy and Nutritional Rehabilitation on Growth in Children Aged 6-36 Months with Severe Acute Malnutrition in IMPAACT Protocol P1092
Mmbaga B, Ngocho J, Tierney C, Ziemba L, Reding C, Bone F, et al.
J Pediatric Infect Dis Soc . 2024 May; 13(8):387-395. PMID: 38808862
Background: Antiretroviral therapy (ART) is known to improve child survival and growth in children living with HIV (CLHIV). We investigated growth outcomes in children with severe nonedematous acute malnutrition (SAM)...
5.
Effects of preterm birth, maternal ART and breastfeeding on 24-month infant HIV-free survival in a randomized trial
Dadabhai S, Chou V, Pinilla M, Chinula L, Owor M, Violari A, et al.
AIDS . 2024 Mar; 38(9):1304-1313. PMID: 38427596
Background: IMPAACT 1077BF/FF (PROMISE) compared the safety/efficacy of two HIV antiretroviral therapy (ART) regimens to zidovudine (ZDV) alone during pregnancy for HIV prevention. PROMISE found an increased risk of preterm...
6.
Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery
Shivakoti R, Giganti M, Lederman M, Ketchum R, Brummel S, Moisi D, et al.
AIDS . 2024 Feb; 38(8):1111-1119. PMID: 38411599
Objective: HIV treatment regimen during pregnancy was associated with preterm delivery (PTD) in the PROMISE 1077 BF trial. Systemic inflammation among pregnant women with HIV could help explain differences in...
7.
Micronutrients and nutritional status among children living with HIV with and without severe acute malnutrition: IMPAACT P1092
Bwakura-Dangarembizi M, Ziemba L, Tierney C, Reding C, Bone F, Bradford S, et al.
BMC Nutr . 2023 Nov; 9(1):121. PMID: 37919816
Background: Micronutrient deficiencies from malabsorption, gut infections, and altered gut barrier function are common in children living with the human immunodeficiency virus (CLHIV) and may worsen with severe acute malnutrition...
8.
Acceptability and Use of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) During Breastfeeding in South Africa, Malawi, Zimbabwe, and Uganda
Stoner M, Hawley I, Mathebula F, Horne E, Etima J, Kemigisha D, et al.
AIDS Behav . 2023 Jul; 27(12):4114-4123. PMID: 37432541
This study examines qualitative acceptability of the dapivirine vaginal ring (DVR) and oral daily pre-exposure prophylaxis (PrEP) among breastfeeding persons participating in Microbicide Trials Network 043/B-PROTECTED, a phase 3B safety...
9.
Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS)
Russell N, Stohr W, Plakkal N, Cook A, Berkley J, Adhisivam B, et al.
PLoS Med . 2023 Jun; 20(6):e1004179. PMID: 37289666
Background: There is limited data on antibiotic treatment in hospitalized neonates in low- and middle-income countries (LMICs). We aimed to describe patterns of antibiotic use, pathogens, and clinical outcomes, and...
10.
Bone and Renal Health in Infants With or Without Breastmilk Exposure to Tenofovir-Based Maternal Antiretroviral Treatment in the PROMISE Randomized Trial
Vhembo T, Baltrusaitis K, Tierney C, Owor M, Dadabhai S, Violari A, et al.
J Acquir Immune Defic Syndr . 2023 May; 93(5):431-437. PMID: 37199427
Background: We assessed bone and kidney outcomes in infants randomized postdelivery as mother-infant pairs within the IMPAACT PROMISE trial to maternal tenofovir disoproxil fumarate-based antiretroviral treatment (mART) or infant nevirapine...